|
ELOX Eloxx Pharmaceuticals Inc 1035354 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-3,754,000.00 |
| Balance Sheet |
|
Current Assets
|
$8,503,000.00 |
|
Assets
|
$8,503,000.00 |
|
Current Liabilities
|
$16,087,000.00 |
|
Liabilities
|
$17,177,000.00 |
|
Equity
|
$-7,584,000.00 |
|
Shares Out
|
5072935.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-5,453,000.00 |
|
Investing Cash Flow
|
$1,000.00 |
| Market Analysis |
Market Cap
|
$67,470,035.50 |
|
Price
|
$17.75 |
|
PB
|
2.22 |
|
EPS
|
-0.08 |
|
FCF
|
$-5,453,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:40 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:39 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ELOX documents filed with the SEC.
ELOX Filings
Clear
